Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial - Concepedia

Concepedia

Publication | Closed Access

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

513

Citations

23

References

2002

Year

Robert J. Lederman, Farrell O. Mendelsohn, R. David Anderson, Jorge F. Saucedo, Alan N. Tenaglia, James Hermiller, William B. Hillegass, Krishna J. Rocha‐Singh, Thomas E. Moon, M.J. Whitehouse,

Regenerative MedicineThrombosisTranslational MedicineAngiogenesisCardiovascular DiseaseVascular AdaptationRandomised TrialPathologyFibroblast Growth FactorVascular BiologyTraffic StudyNeovascularizationVascular Endothelial Growth FactorMedicineTherapeutic AngiogenesisAtherosclerosis

References

	Year	Citations

Page 1

Page 1